"Global Accreditation Failures: How the Wuhan Lab Certification Exposed Systemic Weaknesses and Paved the Way for COVID-19"
ncarol.com/10283922

NEW YORK - ncarol.com -- A series of revelations has exposed the global accreditation industry's vulnerabilities, raising concerns about the integrity of international safety standards. At the center of this controversy is the International Accreditation Forum (IAF is an association of national and international accreditation bodies equivalent in accreditation to ANSI-ANAB), an American-based entity incorporated in Delaware and founded by the American National Standards Institute (ANSI) and the American National Accreditation Board (ANAB). Between 2015 and 2021, the IAF was led by Xiao Jianhua, a Chinese national with deep ties to the Chinese Communist Party and the China National Accreditation Services (CNAS) in Beijing.ANSI took over 100% control of ANAB in 2018.

Key Issues in Global Accreditation

• Leadership and Data Security Concerns: Xiao Jianhua, mandated by China's National Intelligence Law (Article 7), chaired the IAF while simultaneously serving as Chief Executive of CNAS. This dual role raises serious concerns about the transfer of sensitive data to Beijing.
• Wuhan Laboratory Certification: In 2017, Xiao Jianhua issued a certification to the Wuhan Institute of Virology (WIV), a Bio-Level 4 laboratory, despite its lack of preparedness to handle high-contagion pathogens. U.S. contingents inspecting the lab in 2018 discovered insufficiently trained technicians, a critical issue highlighted in CDC training documents in 2019.
• 2017 Pamela Sale's Deposition: Pamela Sale, Vice President of Laboratory Accreditation for ANSI-ANAB, admitted under legal deposition that laboratories lack consistent standards and protocols, further implicating ANSI-ANAB in systematic failures, including the Wuhan lab's deficiencies. "one of the issues is that there is no commonly agreed-upon set of standards that forensics labs around the country have to follow. Instead, there are informal guidelines that labs can choose to follow or not".

Interlocking Directorates and Conflicts of Interest

The FDA, CDC, NIH, and corporations such as Pfizer and Johnson & Johnson sit on ANSI-ANAB board, creating conflicts of interest that compromise regulatory oversight. ANSI and ANAB also serve as underwriters for both the IAF and its sister organization, the International Laboratory Accreditation Cooperation (ILAC in Australia), making them legally responsible for failures resulting from inadequate accreditation.

The Formation of GLOBAC

Reports indicate that ANSI and ANAB are working to merge the IAF and ILAC into a single entity called the Global Accreditation Cooperation (GLOBAC). This move appears to be a strategic effort to absolve ANSI and ANAB of liability while maintaining control over global accreditation processes.

More on ncarol.com

• Kaplan Morrell and Attorney Jacqui Condon Selected to Represent Professional Women's Soccer Players in Workers' Compensation Matters
• ClearSight Therapeutics Receives NIH SBIR Phase I Award for Conjunctivitis and EKC Research
• Lunai Bioworks (N A S D A Q: LNAI) Takes Parkinson's Discovery to the Next Level With Exclusive Tanaist Agreement
• Revenue Optics Names Prat Patibandla Director of Growth Marketing
• VMACS Offers Battery-Powered Heat & AC Systems for RVs and Vans

Implications for Safety and Quality

The implications of these failures extend beyond accreditation. The aerospace, automotive, electronics, and healthcare industries have all experienced systemic issues due to compromised safety standards. Contamination, product recalls, and even loss of life have occurred because of accreditation systems influenced by interlocking directorates of government agencies and corporations.

Cybersecurity Threats Loom: How IAF Leadership and DHS Involvement Created a Gateway for Chinese Espionage

Between 2015 and 2021, a critical security lapse occurred that raises serious questions about potential breaches in U.S. cybersecurity and data protection. During this period, Xiao Jianhua, a Chinese national and then-chairman of the International Accreditation Forum (IAF), also served as the chief executive of the China National Accreditation Services (CNAS). Under China's National Intelligence Law, Article 7, Xiao was mandated to collect data on behalf of the Chinese government.

In a startling revelation, Xiao Jianhua's leadership role in the IAF was handed to him in 2015 by Randy Dougherty, who at the time was serving as Vice President of the American National Standards Institute (ANSI), the American National Accreditation Board (ANAB), and as the IAF chairman and Principal on the IAF 990 tax form. While holding these positions, Dougherty was also prominently featured on the Department of Homeland Security (DHS) website as part of a federal initiative—a potential breach of ethical and legal boundaries.

A Private Enterprise on a Federal Platform: Legal Questions Arise

The inclusion of Randy Dougherty and his private enterprise affiliations (ANSI and ANAB) on a federal government website such as the DHS raises significant concerns about legality and propriety. ANSI and ANAB, both private entities, are not government agencies, yet their leadership was advertised on a federal platform. This raises the question: Is it legal for a federal agency to promote private enterprises in such a manner?

Legal experts suggest that this may violate federal ethics rules, such as those outlined in the Standards of Ethical Conduct for Employees of the Executive Branch (5 CFR Part 2635). These standards prohibit federal endorsement of private entities unless explicitly authorized by law. If no such authorization was granted, this inclusion could represent a misuse of government resources and a conflict of interest.

China's Cybersecurity Inroads

The stakes become even higher considering Xiao Jianhua's dual roles at the IAF and CNAS. The IAF, incorporated in Delaware, is the governing body for global accreditation, and its decisions directly affect industries ranging from aerospace to cybersecurity. Xiao's access to sensitive information, combined with his mandate under Chinese law, created a direct channel for potential data harvesting and cyber espionage.

During this time, Randy Dougherty's presence on the DHS website may have inadvertently legitimized Xiao Jianhua's position and provided China with deeper access to U.S. federal agencies and corporate systems. This raises alarming questions about how a foreign national, obligated to serve the interests of a foreign government, gained such significant influence over international accreditation and indirectly over U.S. cybersecurity infrastructure.

More on ncarol.com

• Independent Autopsies Are Changing Civil Cases: Kansas City Forensic Explains Why Families Are Seeking Second Opinions
• JEGS Launches Transformed Digital Commerce Platform Powered by PhaseZero
• Subject matter experts: Present your ideas at IISE Annual Conference 2027 in Louisville
• Cummings Graduate Institute Celebrates New Doctor of Behavioral Health Graduates
• Data Tiles Challenges the Data Product Status Quo Following Antwerp Summit

A Call for Accountability

The overlap of private enterprises, federal agencies, and foreign influence demonstrates a glaring vulnerability in protecting national security. This situation underscores the urgent need for:

1.         Transparency: Federal agencies must clearly define and justify any associations with private enterprises.

2.         Oversight: Thorough investigations into conflicts of interest and potential breaches of federal ethics laws are imperative.

3.         Cybersecurity Reform: Stricter protocols are required to safeguard sensitive data from foreign actors, especially those with mandated ties to adversarial governments.

This crisis underscores the urgent need for transparency and reform in the global accreditation process. The transfer of leadership to Xiao Jianhua, a Chinese national operating under Communist Party mandates, and the continued influence of conflicted regulatory bodies, pose severe risks to international safety and trust in accreditation systems.

A Warning to the Reader

This issue poses a critical question to Americans: Could China's inroads into federal agencies and corporations between 2015 and 2021 have been facilitated by these lapses? The evidence presented demands serious attention to the potential risks posed by interlocking directorates, foreign mandates, and blurred lines between private and public sectors.

It is imperative that Congress, regulatory bodies, and federal agencies investigate these overlaps and address the systemic flaws that allowed such vulnerabilities to arise.

ALL INFORMATION:
1. Pfizer, J&J, Quality issues
2. 2018 US scientists report about lack of trained technicians in Wuhan China.
3. Volume 25 May 2019 CDC training document
4. Pamela Sale VP Laboratory accreditation for ANSI-ANAB Texas deposition
All contained in this link:  https://www.prlog.org/13052548-covid-vaccine-makers-shielded-until-2029-qa-expert-daryl-guberman-reveals-path-to-justice.html

COVID Vaccine Makers Shielded Until 2029: QA Expert Daryl Guberman Reveals Path to Justice https://www.prlog.org/13052548-covid-vaccine-makers-shielded-until-2029-qa-expert-daryl-guberman-reveals-path-to-justice.html

QA Expert Daryl Guberman Exposes Wuhan Bio-Level-4 And Other Laboratory Certification https://www.prlog.org/12989606-qa-expert-daryl-guberman-exposes-wuhan-bio-level-4-and-other-laboratory-certification.html

***The Link Between J&J's COVID Vaccine and Blood Clots: What
You Need to Know https://www.yalemedicine.org/news/coronavirus-vaccine-blood-clots

Albert Bourla- Certified Veterinarian & PFIZER -CEO (see here: Vax Hesitancy
https://youtu.be/P6O6FqYYImk  )of Pfizer



Benjamin Netanyahu PRIME MINISTER OF Israel:(
https://youtu.be/ItpErus4pSM  )


Who stated that he basically used the Israelis as "labrats" for Pfizer.